Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of Ebola virus disease.

Literature DB >> 25385474

Treatment of Ebola virus disease.

Yazdan Yazdanpanah¹, Jose Ramon Arribas, Denis Malvy.

Abstract

Entities: Disease

Mesh：

Substances：
Antiviral Agents

Year: 2014 PMID： 25385474 DOI： 10.1007/s00134-014-3529-8

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

12 in total

1. First Ebola treatment is approved by WHO.

Authors: Anne Gulland
Journal: BMJ Date: 2014-09-08

2. WHO meeting chooses untried interventions to defeat Ebola.

Authors: John Maurice
Journal: Lancet Date: 2014-09-20 Impact factor: 79.321

3. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors: John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal: Proc Natl Acad Sci U S A Date: 2012-03-12 Impact factor: 11.205

4. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

Authors: Lisa Oestereich; Anja Lüdtke; Stephanie Wurr; Toni Rieger; César Muñoz-Fontela; Stephan Günther
Journal: Antiviral Res Date: 2014-02-26 Impact factor: 5.970

5. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Authors: K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum
Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226

Review 6. Caring for critically ill patients with ebola virus disease. Perspectives from West Africa.

Authors: Robert A Fowler; Thomas Fletcher; William A Fischer; Francois Lamontagne; Shevin Jacob; David Brett-Major; James V Lawler; Frederique A Jacquerioz; Catherine Houlihan; Tim O'Dempsey; Mauricio Ferri; Takuya Adachi; Marie-Claire Lamah; Elhadj Ibrahima Bah; Thierry Mayet; John Schieffelin; Susan L McLellan; Mikiko Senga; Yasuyuki Kato; Christophe Clement; Simon Mardel; Rosa Constanza Vallenas Bejar De Villar; Nahoko Shindo; Daniel Bausch
Journal: Am J Respir Crit Care Med Date: 2014-10-01 Impact factor: 21.405

7. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Authors: Thomas W Geisbert; Amy C H Lee; Marjorie Robbins; Joan B Geisbert; Anna N Honko; Vandana Sood; Joshua C Johnson; Susan de Jong; Iran Tavakoli; Adam Judge; Lisa E Hensley; Ian Maclachlan
Journal: Lancet Date: 2010-05-29 Impact factor: 79.321

8. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors: Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal: Nature Date: 2014-08-29 Impact factor: 49.962

9. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

Authors: Travis K Warren; Jay Wells; Rekha G Panchal; Kelly S Stuthman; Nicole L Garza; Sean A Van Tongeren; Lian Dong; Cary J Retterer; Brett P Eaton; Gianluca Pegoraro; Shelley Honnold; Shanta Bantia; Pravin Kotian; Xilin Chen; Brian R Taubenheim; Lisa S Welch; Dena M Minning; Yarlagadda S Babu; William P Sheridan; Sina Bavari
Journal: Nature Date: 2014-03-02 Impact factor: 49.962

10. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

Authors: Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti
Journal: N Engl J Med Date: 2014-09-22 Impact factor: 91.245

11 in total

1. Ten major priorities for intensive care in India.

Authors: J V Divatia; Shivakumar Iyer
Journal: Intensive Care Med Date: 2015-01-09 Impact factor: 17.440

2. Immunomodulatory adjunctive treatment options for Ebola virus disease patients.

Authors: Peter Pickkers; André van der Ven; Mihai G Netea
Journal: Intensive Care Med Date: 2015-04-02 Impact factor: 17.440

Review 3. Focus on severe infections.

Authors: Kevin B Laupland; Jose-Artur Paiva; Jean-Francois Timsit
Journal: Intensive Care Med Date: 2017-05-13 Impact factor: 17.440

4. Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit.

Authors: P S C Rees; L E M Lamb; T C Nicholson-Roberts; C N Ardley; M S Bailey; D E Hinsley; T E Fletcher; S J Dickson
Journal: Intensive Care Med Date: 2015-03-12 Impact factor: 17.440

Review 5. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Authors: Vincent Madelain; Thi Huyen Tram Nguyen; Anaelle Olivo; Xavier de Lamballerie; Jérémie Guedj; Anne-Marie Taburet; France Mentré
Journal: Clin Pharmacokinet Date: 2016-08 Impact factor: 6.447

6. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Authors: Colleen S Kraft; Angela L Hewlett; Scott Koepsell; Anne M Winkler; Christopher J Kratochvil; LuAnn Larson; Jay B Varkey; Aneesh K Mehta; G Marshall Lyon; Rachel J Friedman-Moraco; Vincent C Marconi; Charles E Hill; James N Sullivan; Daniel W Johnson; Steven J Lisco; Mark J Mulligan; Timothy M Uyeki; Anita K McElroy; Tara Sealy; Shelley Campbell; Christina Spiropoulou; Ute Ströher; Ian Crozier; Richard Sacra; Michael J Connor; Viranuj Sueblinvong; Harold A Franch; Philip W Smith; Bruce S Ribner
Journal: Clin Infect Dis Date: 2015-04-22 Impact factor: 9.079